ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2240

Systematic Review of Skin Nontuberculous Mycobacteria Infection in Systemic Lupus Erythematosus: An Unusual Skin Infection Mimicking Lupus Vasculitis

Zahi Touma1, Amir Haddad2, Dafna D. Gladman3, Elizabeth Uleryk4 and Murray B. Urowitz5, 1Rheumatology, University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, 2Rheumatology, Toronto Western Hospital and University of Toronto, Toronto, ON, Canada, 3Centre for Prognosis Studies in The Rheumatic Diseases, Toronto Western Research Institute, University of Toronto, University Health Network, Toronto, ON, Canada, 4Hospital Library and Archives, The Hospital for Sick Children, Toronto, ON, Canada, 5Division of Rheumatology, University of Toronto, Toronto Western Hospital, Toronto, ON, Canada

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: infection and systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Systemic Lupus Erythematosus: Clinical Aspects

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Nontuberculous mycobacteria (NTM) have become pathogens frequently associated with skin infection in patients on immunosuppression. NTM is not unusual in lupus patients and the unawareness of this complication delays diagnosis and treatment. Studies on infections in lupus identified the common typical bacterial pathogens and little has been published on atypical pathogens in particular NTM.

We aimed to systematically review the medical literature addressing skin NTM in lupus.

 

Methods:

We searched Ovid Medline (1946 to March 12, 2012), Embase (1980 to March 12, 2012) for relevant publications. A study was included in the review if: 1) it included lupus patients with NTM of mucocutaneous system or soft tissue 2) it was published up to March 12, 2012 and 3) it had well-documented clinical summaries and relevant information to the objective of this study. We scanned the titles and abstracts for initial selection. Selected articles were retrieved in full and two reviewers assessed them for eligibility and extracted the data. Descriptive statistics were used to report the results of the analysis.

Results:

Of the 1356 retrieved abstracts, 17 publications were identified and 25 cases of skin NTM were extracted. In this review we included only patients with skin NTM and in all but 5 patients the infection was limited to the skin. The majority of the cases occurred in females (92%). The mean age at the time of the infection was 41 ± 13.3 years, with mean lupus duration of 12.9± 6.7 years. Skin presentations in this review were painless to mildly painful and ranged from papules, plaques, nodules to ulcerative lesions and abscesses and few patients developed constitutional symptoms in particular fever.

NTM in lupus patients occurred after relatively long period from the initial diagnosis of lupus and after the patients had been exposed to steroids and immunosuppressants. NTM occurred in the setting of active as well as inactive lupus. The pathogen species identified in this review included mainly M. Chelonae (9 patient-events [PE]), M. Haemophilum (4 PE), M. Avium (3 PE), M. Kansasii (2 PE), M. Fortuitum (2 PE), M. Scrofulaceum (1 PE), M. Marinatum (1 PE), M. Szulgai (1 PE) and M.abscessus (1 PE). In 4 PE the culture was either negative or the specific species was not identified.

Surgical intervention in particular debridement of skin lesions were considered if needed. Empirical monotherapy therapy can be initially initiated and the final choice of antibiotics should rely on the susceptibility of the culture and clinical response. The majority of the patients’ lesions improved/recovered with treatment. Nevertheless, two patients developed disseminated M. Chelonae and Fortuitum respectively and this resulted in death.

The most commonly used antibiotics in this review were ciprofloxacin, clarithromycin, ethambutol, isoniazide, rifampicin, doxycyline, amikacin, ethambutol and minocycline.

Conclusion:

A high index of suspicion in lupus patients is required to diagnose NTM, as the initial presentation of NTM can mimic lupus skin manifestations. NTM should be suspected in any patient with indolent deep-nodular skin lesions, especially if routine bacterial cultures are negative.

 

 


Disclosure:

Z. Touma,
None;

A. Haddad,
None;

D. D. Gladman,
None;

E. Uleryk,
None;

M. B. Urowitz,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/systematic-review-of-skin-nontuberculous-mycobacteria-infection-in-systemic-lupus-erythematosus-an-unusual-skin-infection-mimicking-lupus-vasculitis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology